NO751118L - - Google Patents

Info

Publication number
NO751118L
NO751118L NO751118A NO751118A NO751118L NO 751118 L NO751118 L NO 751118L NO 751118 A NO751118 A NO 751118A NO 751118 A NO751118 A NO 751118A NO 751118 L NO751118 L NO 751118L
Authority
NO
Norway
Prior art keywords
interferon
solution
agent
urea
approx
Prior art date
Application number
NO751118A
Other languages
English (en)
Norwegian (no)
Inventor
W E Stewart
P M H F De Somer
Original Assignee
Stichting Rega V Z W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega V Z W filed Critical Stichting Rega V Z W
Publication of NO751118L publication Critical patent/NO751118L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO751118A 1974-04-03 1975-04-02 NO751118L (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7404589A NL7404589A (nl) 1974-04-03 1974-04-03 Werkwijze voor het stabiliseren van interferon.

Publications (1)

Publication Number Publication Date
NO751118L true NO751118L (cs) 1975-10-06

Family

ID=19821109

Family Applications (1)

Application Number Title Priority Date Filing Date
NO751118A NO751118L (cs) 1974-04-03 1975-04-02

Country Status (11)

Country Link
US (1) US3981991A (cs)
JP (1) JPS5132725A (cs)
AU (1) AU7951275A (cs)
BE (1) BE826889A (cs)
DE (1) DE2514537A1 (cs)
DK (1) DK139775A (cs)
FI (1) FI750951A7 (cs)
FR (1) FR2266740B3 (cs)
NL (1) NL7404589A (cs)
NO (1) NO751118L (cs)
SE (1) SE7503769L (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100150A (en) * 1975-11-04 1978-07-11 G. D. Searle & Co. Stabilization of interferon against mechanical stress using thioctic acid
FR2351665A1 (fr) * 1976-05-21 1977-12-16 Elf Aquitaine Procede de purification de preparations possedant notamment une activite interferon, preparations purifiees ainsi obtenues et leur application en tant que medicament
US4503035B1 (en) * 1978-11-24 1996-03-19 Hoffmann La Roche Protein purification process and product
IN150740B (cs) * 1978-11-24 1982-12-04 Hoffmann La Roche
US6410697B1 (en) 1979-04-20 2002-06-25 Schering Corporation Process for purifying human leukocyte interferon
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
US4252791A (en) * 1979-10-19 1981-02-24 The Medical College Of Wisconsin, Inc. Interferon stabilization
JP2687995B2 (ja) 1980-04-03 1997-12-08 バイオゲン インコーポレイテッド Ｄｎａ配列、組替えｄｎａ分子およびヒト繊維芽細胞インターフェロン様ポリペプチドの製造方法
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
JPS58167520A (ja) * 1982-03-27 1983-10-03 Sunstar Inc インタ−フエロン安定配合製剤
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
US4681930A (en) * 1983-09-20 1987-07-21 Hoffmann-La Roche Inc. Immune interferon and a method for its extraction and purification
ZA846554B (en) * 1983-09-20 1985-04-24 Hoffmann La Roche Immune interferon and method for its purification
JPS6079000A (ja) * 1983-10-04 1985-05-04 Takeda Chem Ind Ltd ヒトγ型インタ−フエロン単量体の製造法
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
IL74093A0 (en) * 1984-01-23 1985-04-30 Takeda Chemical Industries Ltd Stable composition of gamma-interferon
EP0195084B1 (de) * 1984-09-21 1990-05-23 Vsesojuzny Nauchno-Issledovatelsky Institut Osobo Chistykh Biopreparatov Rektifizierungsverfahren menschlichen leukozyten-interferons
JPS61277633A (ja) * 1985-05-31 1986-12-08 Toray Ind Inc インタ−フエロン組成物
JP2577742B2 (ja) * 1986-07-18 1997-02-05 中外製薬株式会社 安定な顆粒球コロニ−刺激因子含有製剤
US4950470A (en) * 1986-10-06 1990-08-21 Board Of Regents, The University Of Texas System Methods and compositions employing interferon-gamma
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
US6399296B1 (en) * 1994-07-20 2002-06-04 The General Hospital Corporation Interaction trap systems for detecting protein interactions
GB0002660D0 (en) * 2000-02-04 2000-03-29 Biomade B V Method of stabilizing a hydrophobin-containing solution and a method of coatinga surface with a hydrophobin
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano

Also Published As

Publication number Publication date
NL7404589A (nl) 1975-10-07
JPS5132725A (cs) 1976-03-19
SE7503769L (sv) 1975-10-06
DK139775A (cs) 1975-10-04
BE826889A (nl) 1975-09-22
US3981991A (en) 1976-09-21
DE2514537A1 (de) 1975-10-09
FR2266740A1 (cs) 1975-10-31
FR2266740B3 (cs) 1977-12-16
FI750951A7 (cs) 1975-10-04
AU7951275A (en) 1976-09-30

Similar Documents

Publication Publication Date Title
NO751118L (cs)
NO751117L (cs)
Müller et al. The two segments of the infectious bursal disease virus genome are circularized by a 90,000-Da protein
Winick Changes in nucleic acid and protein content of the human brain during growth
Marmur et al. Denaturation of deoxyribonucleic acid by formamide
SE445148B (sv) Forfarande for framstellning av en biologisk komposition for anvendning som en referenskomposition for blodserum vid diagnostisk analys
JPS57140724A (en) Heat-treatment of aqueous solution containing cold insoluble globulin
Tateishi et al. C-terminal truncated Escherichia coli RecA protein RecA5327 has enhanced binding affinities to single-and double-stranded DNAs
Hartshorne et al. The effect of temperature on actomyosin
Centrella et al. Regulation of protein synthesis in vesicular stomatitis virus-infected mouse L-929 cells by decreased protein synthesis initiation factor 2 activity
KR970701199A (ko) 성장 정지 호메오박스 유전자(Growth Arrest Homeobox Gene)
Ballal et al. Dissociation and reconstitution of chromatin without appreciable degradation of the proteins
JP4010573B2 (ja) 低温殺菌中の血漿を安定化するための組成物および治療学的用途のための低温殺菌血漿溶液
KR950700420A (ko) 두개의 유발요소들을 함유한 합성 진핵 세포의 프로모터
Fantl A comparative study of blood coagulation in vertebrates
Alais et al. Isolation, purification, and analysis of two κ-casein-like fractions from sheep casein
JPS6237010B2 (cs)
Hill The effect of the modification of arginine side chains in casein on the coagulation of rennin-altered casein
Meyer et al. Structural studies of the RNA component of the poliovirus replication complex II. Characterization by electron microscopy and autoradiography
Christensen Protamine purification of streptokinase and effect of pH and temperature on reversible inactivation
Treadwell et al. Isolation of protein synthesis initiation factor MP from the high-speed supernatant fraction of wheat germ
NGON Histone H3 thiol reactivity as a probe of nucleosome structure
JPH0475920B2 (cs)
Tonomura et al. On the active site of myosin A-adenosine triphosphatase IV. Properties of binding of trinitrobenzenesulfonate and p-chloromercuribenzoate to myosin a
Cesario et al. Relationship between the physicochemical nature of human interferon, the cell induced, and the inducing agent